3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
4
Infections
3
Thyroid Nodule
2
Neoplasms, Plasma Cell
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia
2
Febrile Neutropenia
2
Urinary Bladder Neoplasms
1
Surgical Wound Infection
1
Sepsis
1
Respiratory Sounds
1
Prostatic Neoplasms
1
Lymphoma, Non-Hodgkin
1
Glioblastoma
1
Emergencies
1
Diverticulitis
1
Cystectomy
1
Brain Neoplasms
1
Astrocytoma
1
Asthma
1
Interventions
Docetaxel
171
Radiotherapy
144
Magnetic Resonance Spectroscopy
142
Leuprolide
112
Prednisone
108
enzalutamide
102
Radiosurgery
101
Abiraterone Acetate
94
Androgen Antagonists
91
Goserelin
83
bicalutamide
81
gallium 68 PSMA-11
70
Surveys and Questionnaires
63
apalutamide
57
Specimen Handling
56
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
55
Radiation
47
Gonadotropin-Releasing Hormone
45
Standard of Care
44
Biopsy
44
Brachytherapy
42
Radiotherapy, Intensity-Modulated
40
Blood Specimen Collection
40
darolutamide
39
abiraterone
39
cabazitaxel
35
Exercise
35
Carboplatin
33
Pluvicto
32
Triptorelin Pamoate
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostatic Neoplasms
×
Amoxicillin-Potassium Clavulanate Combination
×
Clear all
NCT03228108
2022-05-10
pro-SWAP
Radboud University Medical Center
Phase 4
Completed
1,538 enrolled